D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$453M |
| 2 |
Walt Disney
DIS
|
+$410M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$386M |
| 4 |
GE Aerospace
GE
|
+$196M |
| 5 |
Dell
DELL
|
+$188M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$374M |
| 2 |
PayPal
PYPL
|
+$289M |
| 3 |
EMC
EMC CORPORATION
EMC
|
+$278M |
| 4 |
Nike
NKE
|
+$227M |
| 5 |
Amgen
AMGN
|
+$217M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 11.11% |
| 2 | Technology | 10.75% |
| 3 | Financials | 9.5% |
| 4 | Consumer Discretionary | 9.17% |
| 5 | Industrials | 7.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1676
CALL
State Street
STT
$50.7B
| $2.66M | ﹤0.01% |
+38,200
| New | +$2.5M |
|
1677
PUT
Williams-Sonoma
WSM
$27.6B
| $2.66M | ﹤0.01% |
104,000
| – | – |
|
1678
CALL
ANI Pharmaceuticals
ANIP
$1.78B
| $2.65M | ﹤0.01% |
40,000
+10,000
| +33% | +$625K |
|
|
CKH
1679
DELISTED
Seacor Holdings Inc.
CKH
| $2.65M | ﹤0.01% |
46,031
-5,369
| -10% | -$295K |
|
1680
Griffon
GFF
$4.28B
| $2.64M | ﹤0.01% |
155,460
+3,227
| +2% | +$55K |
|
1681
Oxford Industries
OXM
$602M
| $2.64M | ﹤0.01% |
+39,013
| New | +$2.44M |
|
1682
DXP Enterprises
DXPE
$2.57B
| $2.64M | ﹤0.01% |
93,663
+73,573
| +366% | +$1.7M |
|
1683
Boston Beer
SAM
$1.91B
| $2.64M | ﹤0.01% |
16,993
+7,506
| +79% | +$1.31M |
|
1684
LCI Industries
LCII
$2.52B
| $2.63M | ﹤0.01% |
26,862
-17,332
| -39% | -$1.65M |
|
|
VEDL
1685
DELISTED
Vedanta Limited American Depostary Shares (Each representing four equity shares)
VEDL
| $2.63M | ﹤0.01% |
253,316
-81,648
| -24% | -$803K |
|
|
CCMP
1686
DELISTED
CMC Materials, Inc. Common Stock
CCMP
| $2.61M | ﹤0.01% |
49,396
-40,448
| -45% | -$1.99M |
|
1687
CALL
Madison Square Garden
MSGS
$9.57B
| $2.61M | ﹤0.01% |
+21,591
| New | +$2.74M |
|
1688
Core Laboratories
CLB
$518M
| $2.61M | ﹤0.01% |
23,200
+16,375
| +240% | +$1.89M |
|
1689
Dentsply Sirona
XRAY
$2.61B
| $2.6M | ﹤0.01% |
43,801
-87,540
| -67% | -$5.38M |
|
1690
Medifast
MED
$110M
| $2.6M | ﹤0.01% |
68,791
-36,033
| -34% | -$1.29M |
|
|
CS
1691
DELISTED
Credit Suisse Group
CS
| $2.59M | ﹤0.01% |
197,461
+106,911
| +118% | +$1.29M |
|
|
ICON
1692
DELISTED
Iconix Brand Group, Inc.
ICON
| $2.59M | ﹤0.01% |
31,942
+30,100
| +1,634% | +$2.34M |
|
|
TPH
1693
DELISTED
Tri Pointe Homes
TPH
| $2.58M | ﹤0.01% |
195,796
+120,354
| +160% | +$1.59M |
|
1694
Snap-on
SNA
$21.1B
| $2.58M | ﹤0.01% |
16,953
-47,464
| -74% | -$7.33M |
|
1695
CALL
Twilio
TWLO
$29.5B
| $2.57M | ﹤0.01% |
+40,000
| New | +$2M |
|
|
PETX
1696
DELISTED
Aratana Therapeutics, Inc.
PETX
| $2.57M | ﹤0.01% |
+274,982
| New | +$2.28M |
|
|
BPFH
1697
DELISTED
Boston Private Financial Holdings, Inc.
BPFH
| $2.57M | ﹤0.01% |
200,204
-24,340
| -11% | -$302K |
|
1698
PUT
Jabil
JBL
$32.6B
| $2.57M | ﹤0.01% |
117,700
| – | – |
|
|
SCHW
1699
Charles Schwab
SCHW
$181B
| $2.57M | ﹤0.01% |
81,289
-86,643
| -52% | -$2.54M |
|
1700
Capital One
COF
$127B
| $2.56M | ﹤0.01% |
35,708
-356,235
| -91% | -$24.5M |
|
Similar funds
D.E. Shaw & Co's Q3 2016 Portfolio in Review
As of Q3 2016, D.E. Shaw & Co held 3,773 positions worth $56.7B, up 4.5% from $54.2B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
D.E. Shaw & Co's Q3 2016 filing shows 448 new, 1,212 increased, 1,374 reduced and 429 closed positions. Its largest new stake was Dell: 13,808,231 shares worth $185M. The largest sale was Meta Platforms (Facebook), an estimated $374M.
By sector, the portfolio is most concentrated in Healthcare at 11% of assets, down from 11% a quarter earlier, followed by Technology and Financials.
- D.E. Shaw & Co's largest Q3 2016 buy was Dell: 13,808,231 shares worth $185M.
- D.E. Shaw & Co added most to Apple in Q3 2016, an estimated $453M increase.
- D.E. Shaw & Co's biggest Q3 2016 reduction was Meta Platforms (Facebook), cutting an estimated $374M.
- D.E. Shaw & Co fully exited EMC CORPORATION in Q3 2016, selling an estimated $278M.
- D.E. Shaw & Co's ten largest holdings make up 10% of its $56.7B portfolio in Q3 2016.
- D.E. Shaw & Co opened 448 new positions and closed 429 in Q3 2016.
- D.E. Shaw & Co's portfolio value rose 4.5% quarter-over-quarter to $56.7B.
Based on D.E. Shaw & Co's 13F filing for Q3 2016, filed 14 Nov 2016.